Exploiting the PI3K/AKT Pathway for Cancer Drug Discovery

Explore this paper's citation graph

Summary

Recent studies indicate that numerous components of the phosphatidylinositol-3-kinase (PI3K)/AKT pathway are targeted by amplification, mutation and translocation more frequently than any other pathway in cancer patients, with resultant activation of the pathway.

Type
review
Published
2005-12-01
Cited by
2,181
References
191

Keywords

PI3K/AKT/mTOR pathway, Drug discovery, Protein kinase B, Chromosomal translocation, Cancer research

References

Cited by

Related papers